Overview

This book highlights the challenges facing quality assurance/quality control (QA/QC) in today's biopharmaceutical environment and presents the strategic importance and value generated by QA/QC for their involvement in control of manufacturing. It will put into perspective the need for a graded approach to QA/QC from early clinical trials through market approval.

Full Product Details

Author:   John Geigert
Publisher:   Springer Science+Business Media
Imprint:   Kluwer Academic/Plenum Publishers
Edition:   2004 ed.
Dimensions:   Width: 17.80cm , Height: 2.50cm , Length: 25.40cm
Weight:   2.070kg
ISBN:  

9780306480409

ISBN 10:   0306480409
Pages:   350
Publication Date:   31 December 2003
Audience:   General/trade ,  Professional and scholarly ,  College/higher education ,  General ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Awaiting stock  
The supplier is currently out of stock of this item. It will be ordered for you and placed on backorder. Once it does come back in stock, we will ship it out for you.

Table of Contents

1 Biopharmaceutical CMC Regulatory Compliance: What is It?.- 1. Defining Our Terms.- 2. Under the Biopharmaceutical Umbrella.- 3. Regulatory Development of Biopharmaceuticals.- 4. CMC Regulatory Compliance Track Record.- 2 Are Biopharmaceuticals Really Different?.- 1. Perception or Reality.- 2. Regulatory Agencies Speak.- 3. Three Unique CMC Challenges for Biopharmaceuticals.- 4. CMC Meetings with the FDA Take on Greater Importance.- 5. What About CMC Meetings with Emea.- 6. Biopharmaceuticals Need to be Treated Differently.- 3 Developing the Corporate CMC Regulatory Compliance Strateg.- 1. Three Key Elements for a Complete CMC Strategy.- 2. The Minimum CMC Continuum.- 3. Minimum CMC Requirements for Clinical Development.- 4. Full Cmc Requirements For Dossier Filing.- 5. ‘Case-by-Case’ CMC Strategy Specifics.- 4 Can’t Ignore cGMP.- 1. Not Optional.- 2. GMPS for Everything.- 3. Where in the Manufacturing Process Should GMP Begin.- 4. When During Clinical Development Should GMP Begin.- 5. Consequences of not Following GMPS.- 6. Strategic CMC Tips for GMP Compliance.- 5 Recombinant Source Material: Master/Working Bank.- 1. Needed: Reliable, Continuous, Stable Genetic Source.- 2. So Many Hosts to Choose From.- 3. CMC Guidance on Preparation of a Bank.- 4. CMC Guidance on Characterization of a Bank.- 5. A Successful CMC Strategy for Banks.- 6 Production: Expansion of the Recombinant Organism and Expression of the Biopharmaceutica.- 1. Goals: Identity, Capacity and Consistency.- 2. Adequate Description of the Production Process.- 3. Validation of a Cell-Based Production Process.- 4. Additional Production Controls and Concerns.- 5. What Can Go Wrong.- 6. Strategic CMC Tips For Production.- 7 Purification of the Biopharmaceutical.- 1. Goals: Purity, Recovery andConsistency.- 2. Adequate Description of the Purification Process.- 3. Facility and Utility Concerns.- 4. Purification Process Validation.- 5. In-Process Controls.- 6. Process-Related Impurity Profile.- 7. Viral Safety Evaluation.- 8. Purification Controls for Gene Therapy Processes.- 9. What Can Go Wrong.- 8 Biopharmaceutical Drug Product Manufacturing.- 1. Three Basic CMC Regulatory Concerns.- 2. Formulation of a Biopharmaceutical.- 3. Biopharmaceutial Manufacturing Processes.- 4. Adequate Description of the Manufacturing Process.- 5. Adequate Control Over the Manufacturing Process.- 6. What Can Go Wrong.- 7. Strategic CMC Tips for Drug Product Manufacturing.- 9 Physicochemical/Biological Analysis of the Biopharmaceutical Produc.- 1. A Challenging Analysis.- 2. Unraveling the Molecular Properties.- 3. Characterization of Biopharmaceuticals.- 4. Release Testing and Specifications.- 5. Biopharmaceutical Stability and Expiration Dating.- 6. What Can Go Wrong.- 7. Strategic Cmc Tips For Biopharmaceutical Analysis.- 10 Managing Process Changes — Demonstrating Product Comparabilit.- 1. Not As Easy as it Seems.- 2. Regulatory Management of Process Changes.- 3. Demonstrating Product Comparability.- 4. Comparability Protocols.- 5. Case Examples of Biopharmaceutical Comparability.- 11 Biopharmaceutical CMC Outsourcing.- 1. Regulatory Expectations for Contracted Works.- 2. Developing the Intercompany Quality Agreement.- 3. Strategic CMC Tips for Outsourcing.- 12 Concluding Thoughts on Biopharmaceutical CMC Regulatory Compliance.- 1. Most Helpful Websites for Biopharmaceuticals.- 2. Website Resources from FDA.- 3. Resources from Emea.- 4. Resources from Professional Associations.- 5. Conclusion.- References.

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions